PPD broadens infectious disease testing

摘要

Pharmaceutical Development (PPD), a global contract research organisation (CRO) headquartered in the US, has expanded its laboratory testing services in infectious diseases. The Wilmington, NC-based CRO is now able to offer a full range of microbiology testing services, including bacteriology, mycobacteriology and testing of microbioterrorism pathogens at its central laboratories in the US, Belgium, Singapore and China. The laboratory also provides virology testing, including real-time polymerase chain reaction, viral load, genotyping and single nucleotide polymorphism analysis.